Community and topic modeling for infectious disease clinical trial recommendation [PDF]
Clinical trials are crucial for the advancement of treatment and knowledge within the medical community. Although the ClinicalTrials.gov initiative has resulted in a rich source of information for clinical trial research, only a handful of analytic studies have been carried out to understand this valuable data source. Analysis of this database provides
Magdalyn E. Elkin, Xingquan Zhu
openalex +3 more sources
Methodological and statistical topics in randomized controlled clinical trials [PDF]
Cláudia Caminha Escosteguy
+10 more sources
Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003 [PDF]
Jean‐Michel Pawlotsky+1 more
openalex +2 more sources
What is an “ongoing” clinical trial? An analysis of different sources revealed heterogeneous definitions of when a clinical trial starts and ends: a meta-research study [PDF]
BACKGROUND: Although the concept of an “ongoing study” seems self-explanatory, it is difficult to determine whether a trial is underway. OBJECTIVE: To analyze the definitions of “ongoing clinical trial” across different clinical trial registries ...
Rafael Leite Pacheco+2 more
doaj +1 more source
Clinical Trials in Portugal: How Can we Improve?
N/a.
Marta Carvalho+9 more
doaj +1 more source
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy
Phage therapy has become a hot topic in medical research due to the increasing prevalence of antibiotic-resistant bacteria strains. In the treatment of bacterial infections, bacteriophages have several advantages over antibiotics, including strain ...
L. Marongiu+4 more
semanticscholar +1 more source
Introduction: The aim of this study was to investigate the Portuguese authorship in publications resulting from trials initiated by the industry or investigators and run in Portugal.
Maria Pinheiro Andrade+6 more
doaj +1 more source
Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology
PURPOSE Proportionate minority representation in clinical trials is an important step toward addressing health care inequities. Given the paucity of data on this topic in urologic oncology, we sought to quantify the enrollment of minority patients in ...
J. Owens-Walton+4 more
semanticscholar +1 more source
A summary of current NKG2D-based CAR clinical trials
Summary Cancer immunotherapies have significantly improved patient survival and treatment options in recent years. Nonetheless, the success of immunotherapy is limited to certain cancer types and specific subgroups of patients, making the development of ...
Sophie Curio+2 more
semanticscholar +1 more source